Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lympho
ClinicalTrials.gov study NCT01471210. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Clinical Study of Cord Blood-derived IL-10/IL-15 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL
ClinicalTrials.gov study NCT06707259. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT04173988. IPD Sharing: NO. Countries: 1. Publications: 0.
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05436223. IPD Sharing: NO. Countries: 1. Publications: 0.
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT05365659. IPD Sharing: NO. Countries: 5. Publications: 0.
Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies
ClinicalTrials.gov study NCT04684979. IPD Sharing: NO. Countries: 1. Publications: 0.
"Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL
ClinicalTrials.gov study NCT06919393. IPD Sharing: NO. Countries: 1. Publications: 0.
Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT04626726. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)
ClinicalTrials.gov study NCT07072169. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction
ClinicalTrials.gov study NCT03217253. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma
ClinicalTrials.gov study NCT05755828. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.
ClinicalTrials.gov study NCT05896163. IPD Sharing: YES. Countries: 5. Publications: 0.
UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
ClinicalTrials.gov study NCT06743503. IPD Sharing: NO. Countries: 1. Publications: 0.
Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00485966. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Golcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT07269639. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies
ClinicalTrials.gov study NCT01805375. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT07189065. IPD Sharing: NO. Countries: 1. Publications: 0.
ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05025800. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib
ClinicalTrials.gov study NCT03701438. IPD Sharing: YES. Countries: 2. Publications: 0.
A Study of Universal CD19-Targeted UCAR-NK Cells Combined With HSCT for B Cell Hematologic Malignancies
ClinicalTrials.gov study NCT05654038. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.